Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomized, Controlled, Open-labeled (Dose-blinded) Dose Finding Study of the Safety and Efficacy of I-040202 in the Treatment of Patients With Acute Open Tibial Shaft Fractures

NCT00533793 is registered in ClinicalTrials.gov with Kuros Biosurgery AG as lead sponsor.

NCT NCT00533793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00533793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomized, Controlled, Open-labeled (Dose-blinded) Dose Finding Study of the Safety and Efficacy of I-040202 in the Treatment of Patients With Acute Open Tibial Shaft Fractures
Lead sponsor
Kuros Biosurgery AG
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2007
Completion date
May 31, 2011
Enrollment
201 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

trauma